Intrinsiqq
Chemed Corporation logo

Chemed Corporation Quality Score

CHE

⊜ Compare
Quality60

Growth is the primary weakness (avg 60/100). Valuation is the relative bright spot.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
60/100
26.3x

25–30x, paying a growth premium

Cash Flow Multiple
80/100
24.2x

20–25x, moderate cash flow premium

Revenue Growth
70/100
5.7%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
50/100
4.0%

2–5% CAGR, growing but slowly

Business Quality & Capital Allocation

Share Dilution
100/100
-13.0%

Shrinking >2%, active buybacks

Margin Trend
0/100
-2.2pp

Contracted >2pp, margin pressure

Capital Structure
40/100
$344M

Net debt/FCF of 1.2x, somewhat elevated

2022
$74.0M
$247M
2023
$264M
$139M
2024
$178M
$141M
2025
$75.0M
$144M
TTM
$48.0M
$392M
CashDebt
Return on Capital
100/100
23.6%

Above 20%, exceptional capital efficiency

Customize WeightsPremiumUpgrade

Chemed (CHE) quality: score, margins and returns

Chemed (CHE) scores 60/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 8 metrics each scored 0 to 100, on 13.9% operating margins and 23.6% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Chemed (CHE) a high-quality business?+

Chemed scores 60 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a 13.9% operating margin and a 23.6% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Chemed's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from CHE's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Chemed scores well and where it falls behind.

What is Chemed's return on invested capital (ROIC)?+

Chemed earns about 23.6% on its invested capital, which is exceptional. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to CHE's margins and growth on this scorecard to judge durability.

How profitable is Chemed?+

Chemed runs an operating margin of about 13.9% and a net margin of about 10.6%. Revenue has grown at roughly 4.0% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 30 Sept 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 30 Oct 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Services-Home Health Care Services · Pick stocks to compare with CHE

CompareIntrinsic value
AVAHAveanna Healthcare Holdings Inc.
$14.23+7.15%41
AHCOAdaptHealth Corp.
$7.31+16.40%31
ADUSAddus HomeCare Corporation
$128.02+1.16%79
EHABEnhabit, Inc.
No recent price8
OPCHOption Care Health Inc.
$31.65-0.38%48
BTSGBrightSpring Health Services, Inc.
$69.80-0.06%58
FTREFortrea Holdings Inc.
$20.74-1.00%29
NTRANATERA INC (Common Stock) – ticker 45E
$391.03+0.62%61

Held by ETFs

CHE is in 147 US ETFs. The largest of them, with CHE's weight in each:

Spot a number that looks wrong? Check it in CHE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CHE

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.